Equities

TianYu Bio-Technology Co Ltd

603717:SHH

TianYu Bio-Technology Co Ltd

Actions
IndustrialsConstruction and Materials
  • Price (CNY)4.96
  • Today's Change-0.02 / -0.40%
  • Shares traded3.56m
  • 1 Year change-27.70%
  • Beta1.0896
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments105242176
Total Receivables, Net1,2261,3541,687
Total Inventory160240106
Prepaid expenses7931100
Other current assets, total5847154
Total current assets1,6271,9142,223
Property, plant & equipment, net522362233
Goodwill, net5.565.565.00
Intangibles, net7.127.82105
Long term investments106259101
Note receivable - long term890815611
Other long term assets------
Total assets3,2733,4613,329
LIABILITIES
Accounts payable681628630
Accrued expenses707065
Notes payable/short-term debt192214283
Current portion long-term debt/capital leases10473317
Other current liabilities, total192146129
Total current liabilities1,2381,1311,424
Total long term debt1,033859253
Total debt1,3281,146853
Deferred income tax0.070.260.58
Minority interest189294194
Other liabilities, total1683740
Total liabilities2,6272,3201,911
SHAREHOLDERS EQUITY
Common stock290290290
Additional paid-in capital932932930
Retained earnings (accumulated deficit)(576)(82)198
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity6461,1401,418
Total liabilities & shareholders' equity3,2733,4613,329
Total common shares outstanding290290290
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.